Found 10 matching trials
Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)
PHASE3This is a multicenter, randomized, observer-blinded, controlled, immune equ...
Location
Lingga Health Research Center
Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
PHASE3Phase III study, Randomized, observer blind, lot to lot consistency, non in...
Location
Jatinegara Primary Health Care
Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh
PHASE1This is a double blinded, randomized-controlled, non-inferiority trial of a...
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants
PHASE2This study is to assess the safety and immunogenicity of Vi-DT vaccine in a...
Location
Puskesmas Jatinegara
Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
PHASE2Vi-DT Typhoid vaccine is a novel vaccine. This study will be done to know t...
Location
Puskesmas Jatinegara
Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine
PHASE3This is a Multicenter, observer-blinded, randomized, Active controlled, Pha...
Location
Nepalgunj medical college
Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)
PHASE1This study is to assess the safety of Vi-DT vaccine in adults and children....
Location
Puskesmas Jatinegara
Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCV
N/ATyphoid fever is a serious systemic infection caused by the enteric pathoge...
Location
Department of Child Health Dr. Soetomo Hospital/School of Medicine, Airlangga University, Surabaya, East Java
Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
PHASE1This is a Phase I, Randomized, observer-blinded, age de-escalating study.
...
Location
Multiple Locations
Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine
PHASE2This is a randomized, observer-blinded Phase 2 study in healthy infants and...
Location
Research Institute for Tropical Medicine(RITM)